413 related articles for article (PubMed ID: 22288676)
41. Low-dose tissue plasminogen activator and standard-dose tissue plasminogen activator in acute ischemic stroke in Asian populations: a review.
Ramaiah SS; Yan B
Cerebrovasc Dis; 2013; 36(3):161-6. PubMed ID: 24135524
[TBL] [Abstract][Full Text] [Related]
42. Plasminogen activation and thrombolysis for ischemic stroke.
Medcalf RL; Davis SM
Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
[TBL] [Abstract][Full Text] [Related]
43. Different doses of recombinant tissue-type plasminogen activator for acute stroke in Chinese patients.
Chao AC; Liu CK; Chen CH; Lin HJ; Liu CH; Jeng JS; Hu CJ; Chung CP; Hsu HY; Sheng WY; Hu HH;
Stroke; 2014 Aug; 45(8):2359-65. PubMed ID: 24994721
[TBL] [Abstract][Full Text] [Related]
44. Dosing of tissue plasminogen activator often differs from 0.9 mg/kg, but does not affect the outcome.
Aulicky P; Rabinstein A; Seet RC; Neumann J; Mikulik R
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1293-7. PubMed ID: 23246191
[TBL] [Abstract][Full Text] [Related]
45. Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
Liu H; Zheng H; Cao Y; Pan Y; Wang D; Zhang R; You S; Zhang X; Li S; Tong X; Liu CF; Wang Y
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):988-997. PubMed ID: 29224744
[TBL] [Abstract][Full Text] [Related]
46. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data.
Graham GD
Stroke; 2003 Dec; 34(12):2847-50. PubMed ID: 14605319
[TBL] [Abstract][Full Text] [Related]
47. Intravenous alteplase for acute ischemic stroke in patients with current malignant neoplasm.
Cappellari M; Carletti M; Micheletti N; Tomelleri G; Ajena D; Moretto G; Bovi P
J Neurol Sci; 2013 Feb; 325(1-2):100-2. PubMed ID: 23317922
[TBL] [Abstract][Full Text] [Related]
48. Thrombolysis for acute ischemic stroke in South Africa.
Bryer A; Wasserman S
Int J Stroke; 2013 Oct; 8 Suppl A100():112-3. PubMed ID: 23692573
[TBL] [Abstract][Full Text] [Related]
49. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.
Piriyawat P; Labiche LA; Burgin WS; Aronowski JA; Grotta JC
Stroke; 2003 May; 34(5):1242-5. PubMed ID: 12690224
[TBL] [Abstract][Full Text] [Related]
50. Thrombolysis in dementia patients with acute stroke: is it justified?
Paciaroni M; Pantoni L
Neurol Sci; 2017 Jan; 38(1):27-31. PubMed ID: 27699498
[TBL] [Abstract][Full Text] [Related]
51. Current indications and results of thrombolysis by intravenous recombinant tissue plasminogen activator.
Tari Capone F; Cavallari M; Casolla B; Orzi F
Tech Vasc Interv Radiol; 2012 Mar; 15(1):10-8. PubMed ID: 22464298
[TBL] [Abstract][Full Text] [Related]
52. Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation.
Suwanwela NC; Phanthumchinda K; Likitjaroen Y
Clin Neurol Neurosurg; 2006 Sep; 108(6):549-52. PubMed ID: 16289309
[TBL] [Abstract][Full Text] [Related]
53. [Thrombolytic therapy: formation and current practice of intravenous thrombolysis in acute ischemic stroke].
Iavorskaia VA; Flomin IuV; D'olog NV; Grebeniuk AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():13-27. PubMed ID: 16447549
[TBL] [Abstract][Full Text] [Related]
54. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
[TBL] [Abstract][Full Text] [Related]
55. Thrombolysis for Ischemic Stroke during Pregnancy: A Case Report and Review of the Literature.
Tversky S; Libman RB; Reppucci ML; Tufano AM; Katz JM
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e167-70. PubMed ID: 27523596
[TBL] [Abstract][Full Text] [Related]
56. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies.
Tsivgoulis G; Eggers J; Ribo M; Perren F; Saqqur M; Rubiera M; Sergentanis TN; Vadikolias K; Larrue V; Molina CA; Alexandrov AV
Stroke; 2010 Feb; 41(2):280-7. PubMed ID: 20044531
[TBL] [Abstract][Full Text] [Related]
57. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
Weintraub MI
Stroke; 2006 Jul; 37(7):1917-22. PubMed ID: 16728683
[TBL] [Abstract][Full Text] [Related]
58. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
Palesch YY; Hill MD; Ryckborst KJ; Tamariz D; Ginsberg MD
Stroke; 2006 Aug; 37(8):2107-14. PubMed ID: 16809570
[TBL] [Abstract][Full Text] [Related]
59. Thrombolysis in acute ischemic stroke is associated with lower long-term hospital bed day use: A nationwide propensity score-matched follow-up study.
Terkelsen T; Schmitz ML; Simonsen CZ; Hundborg HH; Christensen HK; Gyllenborg J; Sandal BF; Iversen HK; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
Int J Stroke; 2016 Oct; 11(8):910-916. PubMed ID: 27312677
[TBL] [Abstract][Full Text] [Related]
60. Intravenous thrombolysis for ischemic stroke in recurrent oligodendroglioma: a case report.
Dafer RM; Paleologos N; Lynch D
J Stroke Cerebrovasc Dis; 2014; 23(5):1235-8. PubMed ID: 24103669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
